首页 | 官方网站   微博 | 高级检索  
     

扶正抗癌方诱导H1650细胞凋亡的分子机制
引用本文:李龙妹,吴万垠,王苏美,龙顺钦,杨小兵,周宇姝.扶正抗癌方诱导H1650细胞凋亡的分子机制[J].中国实验方剂学杂志,2016,22(14):106-110.
作者姓名:李龙妹  吴万垠  王苏美  龙顺钦  杨小兵  周宇姝
作者单位:广州中医药大学 第二临床医学院, 广州 510006,广东省中医院 芳村分院, 广州 510370,广东省中医院 芳村分院, 广州 510370,广东省中医院 芳村分院, 广州 510370,广东省中医院 芳村分院, 广州 510370,广东省中医院 芳村分院, 广州 510370
基金项目:国家自然科学基金项目(81273965,81503507);广东省自然科学基金项目(2015A030310245);广东省建设中医药强省科研项目(20141104)
摘    要:目的:观察扶正抗癌方对H1650细胞凋亡的影响,并探讨其诱导H1650细胞凋亡的分子机制。方法:以人肺腺癌细胞株H1650细胞为研究对象,用0.5,1.0,1.5,2.0,2.5,3.0 g·L~(-1)扶正抗癌方处理H1650细胞24,48,72 h,另设空白组,四氮唑蓝盐化合物(MTS)法检测细胞增殖;用0.5,1.0,1.5 g·L~(-1)扶正抗癌方处理H1650细胞24 h,另设空白组,Annexin VFITC/碘化丙啶(PI)流式细胞术检测细胞凋亡;用0.5,1.0,2.0 g·L~(-1)扶正抗癌方处理H1650细胞24 h,另设空白组,半胱氨酸蛋白酶-3/7(Caspase-3/7)活力检测试剂盒检测Caspase-3/7活力;蛋白免疫印迹法检测扶正抗癌方对pro Casapse-3,聚腺苷二磷酸-核糖聚合酶(PARP),Bcl-2相关X蛋白(Bax)表达。结果:与空白组比较,扶正抗癌方能明显抑制H1650细胞的增殖(P0.05),且呈浓度和时间依赖性。与空白组比较,扶正抗癌方明显诱导H1650细胞的早期凋亡,增强Caspase-3/7的活力(P0.05),且呈浓度依赖性。与空白组比较,扶正抗癌方明显下调pro Casapse-3和PARP的表达(P0.05),呈浓度依赖性,明显上调Bax的表达(P0.05),且呈时间依赖性。结论:扶正抗癌方可通过激活Caspase-3和Bax诱导H1650细胞的凋亡。

关 键 词:扶正抗癌方  细胞凋亡  半胱氨酸蛋白酶-3/7  Bcl-2相关X蛋白
收稿时间:2015/12/30 0:00:00

Molecular Mechanism of Fuzheng Kang'ai Decoction in Inducing Apoptosis of H1650 Cells
LI Long-mei,WU Wan-yin,WANG Su-mei,LONG Shun-qin,YANG Xiao-bing and ZHOU Yu-shu.Molecular Mechanism of Fuzheng Kang'ai Decoction in Inducing Apoptosis of H1650 Cells[J].China Journal of Experimental Traditional Medical Formulae,2016,22(14):106-110.
Authors:LI Long-mei  WU Wan-yin  WANG Su-mei  LONG Shun-qin  YANG Xiao-bing and ZHOU Yu-shu
Affiliation:The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510006, China,Fangcun Branch, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510370, China,Fangcun Branch, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510370, China,Fangcun Branch, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510370, China,Fangcun Branch, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510370, China and Fangcun Branch, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510370, China
Abstract:Objective: To observe the effects of Fuzheng Kang''ai (FZKA) decoction on apoptosis of H1650 cells and discuss its molecular mechanism in apoptosis of H1650 cells. Method: Human lung adenocarcinoma cells (H1650 cells) were used as the research objects and treated for 24, 48, 72 h with 0.5, 1.0, 1.5, 2.0, 2.5, 3.0 g · L-1 FZKA decoction, and a blank group was set up, then cell proliferation was detected by 3- (4, 5-diethylthiazol-2-yl)-5- (3-carboxymethoxyphenyl)-2- (4-sulfophenyl)-2H-etrazolium, inner salt (MTS) assay. H1650 cells were treated for 24 h with 0.5, 1.0, 1.5 g · L-1 FZKA decoction and a blank group was set up, then cell apoptosis was detected by Annexin V-FITC/PI flow cytometry analysis. H1650 cells were treated for 24 h with 0.5, 1.0, 2.0 g · L-1 FZKA decoction and a blank group was set up, then vitality of Caspase-3/7 was detected by Caspase-3/7 vitality test kit. Simultaneously, effects of FZKA decoction on the expression levels of proCasapse-3, PARP and Bax were detected by Western blot assay. Result: As compared with the blank group, proliferation of H1650 cells was significantly inhibited by FZKA decoction in concentration-dependent and time-dependent manners (P<0.05). As compared with the blank group, early apoptosis of H1650 cells was significantly induced and vitality of Caspase-3/7 was increased by FZKA decoction in a concentration-dependent manner (P<0.05). As compared with the blank group, the expression levels of proCasapse-3 and PARP were significantly reduced by FZKA decoction in a concentration-dependent manner (P<0.05), and the expression of Bax was increased by FZKA decoction in a time-dependent manner (P<0.05). Conclusion: Apoptosis is induced by FZKA decoction in way of activating Caspase-3 and Bax in H1650 cells.
Keywords:Fuzheng Kang''ai  decoction  apoptosis  Caspase-3/7  Bax
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号